Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperparathyroidism, Primary | 6 | 2023 | 32 | 1.860 |
Why?
|
| Environmental Exposure | 7 | 2025 | 298 | 1.390 |
Why?
|
| Laparoscopy | 5 | 2022 | 537 | 1.240 |
Why?
|
| Trihalomethanes | 3 | 2020 | 5 | 1.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2024 | 102 | 0.960 |
Why?
|
| Gastroesophageal Reflux | 4 | 2024 | 325 | 0.960 |
Why?
|
| Environmental Monitoring | 5 | 2026 | 99 | 0.950 |
Why?
|
| Parathyroidectomy | 5 | 2023 | 51 | 0.890 |
Why?
|
| School Health Services | 1 | 2026 | 103 | 0.890 |
Why?
|
| Child Health | 1 | 2026 | 72 | 0.870 |
Why?
|
| Fundoplication | 3 | 2024 | 71 | 0.830 |
Why?
|
| Schools | 1 | 2026 | 238 | 0.810 |
Why?
|
| Occupational Exposure | 2 | 2026 | 135 | 0.740 |
Why?
|
| Health Promotion | 1 | 2026 | 421 | 0.720 |
Why?
|
| Brain Concussion | 1 | 2024 | 252 | 0.710 |
Why?
|
| Water Pollutants, Chemical | 3 | 2020 | 37 | 0.690 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2022 | 64 | 0.680 |
Why?
|
| Natural Orifice Endoscopic Surgery | 3 | 2024 | 78 | 0.620 |
Why?
|
| Thyroid Diseases | 2 | 2016 | 27 | 0.580 |
Why?
|
| Disinfectants | 1 | 2019 | 27 | 0.580 |
Why?
|
| Esophagus | 2 | 2011 | 233 | 0.570 |
Why?
|
| Manufacturing and Industrial Facilities | 1 | 2018 | 1 | 0.550 |
Why?
|
| Methylene Chloride | 1 | 2018 | 1 | 0.550 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2016 | 1457 | 0.550 |
Why?
|
| Prediabetic State | 1 | 2019 | 68 | 0.550 |
Why?
|
| Nursing Staff, Hospital | 1 | 2019 | 65 | 0.540 |
Why?
|
| Aged, 80 and over | 13 | 2026 | 6773 | 0.540 |
Why?
|
| Air Pollution | 1 | 2018 | 79 | 0.510 |
Why?
|
| Registries | 1 | 2024 | 1617 | 0.500 |
Why?
|
| Cyprus | 3 | 2024 | 3 | 0.500 |
Why?
|
| Thyroid Gland | 1 | 2016 | 96 | 0.470 |
Why?
|
| Phenols | 1 | 2016 | 73 | 0.470 |
Why?
|
| Aged | 20 | 2026 | 20917 | 0.470 |
Why?
|
| Middle Aged | 21 | 2024 | 28454 | 0.470 |
Why?
|
| Benzhydryl Compounds | 1 | 2016 | 79 | 0.470 |
Why?
|
| Herniorrhaphy | 2 | 2026 | 71 | 0.430 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 685 | 0.420 |
Why?
|
| Anastomosis, Roux-en-Y | 2 | 2011 | 19 | 0.390 |
Why?
|
| Humans | 44 | 2026 | 130611 | 0.380 |
Why?
|
| Veterans | 2 | 2025 | 1756 | 0.370 |
Why?
|
| Air Pollutants | 1 | 2014 | 124 | 0.370 |
Why?
|
| Adult | 16 | 2024 | 31146 | 0.350 |
Why?
|
| Young Adult | 11 | 2024 | 10042 | 0.350 |
Why?
|
| Body Mass Index | 5 | 2019 | 1704 | 0.350 |
Why?
|
| Europe | 4 | 2026 | 364 | 0.350 |
Why?
|
| Microsurgery | 1 | 2011 | 66 | 0.340 |
Why?
|
| Male | 25 | 2026 | 64659 | 0.330 |
Why?
|
| Colectomy | 1 | 2011 | 89 | 0.330 |
Why?
|
| Adolescent | 12 | 2026 | 20893 | 0.330 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2016 | 400 | 0.330 |
Why?
|
| Female | 27 | 2026 | 70631 | 0.320 |
Why?
|
| Neoplasms | 2 | 2024 | 2993 | 0.320 |
Why?
|
| Age Distribution | 2 | 2024 | 421 | 0.320 |
Why?
|
| Age Factors | 3 | 2024 | 2818 | 0.310 |
Why?
|
| Deglutition Disorders | 1 | 2011 | 132 | 0.300 |
Why?
|
| Stomach | 1 | 2011 | 270 | 0.290 |
Why?
|
| Jejunum | 1 | 2009 | 123 | 0.290 |
Why?
|
| General Surgery | 1 | 2011 | 224 | 0.280 |
Why?
|
| Surgical Stapling | 1 | 2008 | 18 | 0.280 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2008 | 14 | 0.280 |
Why?
|
| Iodine | 2 | 2020 | 20 | 0.280 |
Why?
|
| Esophagoscopy | 1 | 2010 | 173 | 0.280 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 1306 | 0.280 |
Why?
|
| Gastric Bypass | 1 | 2009 | 97 | 0.280 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2010 | 105 | 0.270 |
Why?
|
| Focus Groups | 2 | 2026 | 239 | 0.270 |
Why?
|
| Gastrostomy | 1 | 2008 | 84 | 0.270 |
Why?
|
| Osteoporosis | 2 | 2025 | 133 | 0.250 |
Why?
|
| Obesity | 2 | 2019 | 2416 | 0.250 |
Why?
|
| Halogenation | 2 | 2016 | 6 | 0.250 |
Why?
|
| Bone Density | 2 | 2023 | 366 | 0.240 |
Why?
|
| Consensus | 2 | 2026 | 510 | 0.240 |
Why?
|
| Parathyroid Hormone | 3 | 2023 | 83 | 0.240 |
Why?
|
| Anesthesia, Local | 1 | 2026 | 40 | 0.230 |
Why?
|
| Hernia, Inguinal | 1 | 2026 | 40 | 0.230 |
Why?
|
| Retrospective Studies | 9 | 2022 | 17662 | 0.230 |
Why?
|
| Bone and Bones | 2 | 2024 | 308 | 0.220 |
Why?
|
| Blood Glucose | 2 | 2019 | 1113 | 0.220 |
Why?
|
| Qualitative Research | 2 | 2026 | 722 | 0.220 |
Why?
|
| Bone Remodeling | 1 | 2025 | 56 | 0.220 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2024 | 65 | 0.210 |
Why?
|
| Physicians | 1 | 2011 | 629 | 0.210 |
Why?
|
| Hernia, Hiatal | 1 | 2024 | 55 | 0.210 |
Why?
|
| Clinical Competence | 1 | 2011 | 1046 | 0.210 |
Why?
|
| Prospective Studies | 7 | 2019 | 6432 | 0.200 |
Why?
|
| Occupational Health | 2 | 2026 | 43 | 0.200 |
Why?
|
| Biomarkers | 7 | 2026 | 3371 | 0.200 |
Why?
|
| Motivation | 1 | 2025 | 328 | 0.200 |
Why?
|
| Pesticides | 1 | 2023 | 26 | 0.190 |
Why?
|
| Terminology as Topic | 1 | 2024 | 226 | 0.190 |
Why?
|
| Patient Participation | 1 | 2025 | 253 | 0.190 |
Why?
|
| Fluorocarbons | 1 | 2023 | 66 | 0.180 |
Why?
|
| Adrenalectomy | 1 | 2022 | 30 | 0.180 |
Why?
|
| Environmental Pollutants | 1 | 2023 | 78 | 0.180 |
Why?
|
| Arsenic | 1 | 2023 | 48 | 0.180 |
Why?
|
| Patient Selection | 1 | 2025 | 724 | 0.180 |
Why?
|
| Sensitivity and Specificity | 2 | 2024 | 2080 | 0.170 |
Why?
|
| Logistic Models | 2 | 2016 | 1796 | 0.170 |
Why?
|
| Child | 7 | 2026 | 26262 | 0.170 |
Why?
|
| Case-Control Studies | 3 | 2017 | 3350 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2024 | 2062 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 1262 | 0.160 |
Why?
|
| Treatment Failure | 2 | 2011 | 348 | 0.150 |
Why?
|
| Body Weights and Measures | 1 | 2019 | 33 | 0.150 |
Why?
|
| Thymectomy | 1 | 2019 | 24 | 0.150 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 337 | 0.140 |
Why?
|
| Thymoma | 1 | 2019 | 19 | 0.140 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2019 | 105 | 0.140 |
Why?
|
| Parathyroid Glands | 2 | 2023 | 26 | 0.140 |
Why?
|
| Margins of Excision | 1 | 2019 | 60 | 0.140 |
Why?
|
| Linear Models | 2 | 2020 | 687 | 0.140 |
Why?
|
| Hospitals, Public | 1 | 2019 | 48 | 0.140 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 356 | 0.140 |
Why?
|
| Thymus Neoplasms | 1 | 2019 | 39 | 0.140 |
Why?
|
| Shift Work Schedule | 1 | 2019 | 30 | 0.140 |
Why?
|
| Circadian Clocks | 1 | 2019 | 84 | 0.140 |
Why?
|
| Incidence | 2 | 2024 | 3336 | 0.140 |
Why?
|
| Postoperative Complications | 3 | 2018 | 3130 | 0.140 |
Why?
|
| Hernia, Abdominal | 1 | 2018 | 19 | 0.140 |
Why?
|
| Dietary Fats | 1 | 2019 | 278 | 0.140 |
Why?
|
| Causality | 1 | 2018 | 89 | 0.130 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 268 | 0.130 |
Why?
|
| United States | 5 | 2026 | 12030 | 0.130 |
Why?
|
| Robotics | 1 | 2019 | 102 | 0.130 |
Why?
|
| Reoperation | 2 | 2011 | 816 | 0.130 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 319 | 0.130 |
Why?
|
| Treatment Outcome | 7 | 2024 | 12862 | 0.120 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2017 | 70 | 0.120 |
Why?
|
| Thyrotropin | 1 | 2016 | 49 | 0.120 |
Why?
|
| Time Factors | 2 | 2024 | 6168 | 0.120 |
Why?
|
| Thyroxine | 1 | 2016 | 53 | 0.120 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 341 | 0.120 |
Why?
|
| Immunoassay | 1 | 2016 | 126 | 0.120 |
Why?
|
| Chromatin | 1 | 2019 | 499 | 0.120 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2020 | 723 | 0.120 |
Why?
|
| Child, Preschool | 3 | 2024 | 15048 | 0.120 |
Why?
|
| Cerebral Hemorrhage | 1 | 2017 | 157 | 0.120 |
Why?
|
| Health Behavior | 1 | 2019 | 386 | 0.120 |
Why?
|
| Infant | 2 | 2024 | 13308 | 0.120 |
Why?
|
| Alanine Transaminase | 1 | 2016 | 153 | 0.120 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2020 | 478 | 0.110 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 1283 | 0.110 |
Why?
|
| Acute Kidney Injury | 2 | 2014 | 705 | 0.110 |
Why?
|
| Sex Factors | 1 | 2019 | 1348 | 0.110 |
Why?
|
| Brain Ischemia | 1 | 2017 | 266 | 0.110 |
Why?
|
| Creatinine | 1 | 2016 | 398 | 0.110 |
Why?
|
| Leptin | 1 | 2016 | 218 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 2019 | 803 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 286 | 0.100 |
Why?
|
| Swimming | 1 | 2014 | 25 | 0.100 |
Why?
|
| Interviews as Topic | 2 | 2026 | 464 | 0.100 |
Why?
|
| Smoking | 1 | 2019 | 930 | 0.100 |
Why?
|
| Cystatin C | 1 | 2014 | 70 | 0.100 |
Why?
|
| Robotic Surgical Procedures | 1 | 2018 | 224 | 0.100 |
Why?
|
| Etidronic Acid | 1 | 2013 | 10 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2016 | 1209 | 0.100 |
Why?
|
| Tibia | 1 | 2013 | 86 | 0.090 |
Why?
|
| Parathyroid Neoplasms | 1 | 2012 | 20 | 0.090 |
Why?
|
| Choristoma | 1 | 2012 | 43 | 0.090 |
Why?
|
| Liver | 1 | 2019 | 1789 | 0.090 |
Why?
|
| Heartburn | 1 | 2011 | 17 | 0.090 |
Why?
|
| Chromium | 1 | 2011 | 7 | 0.090 |
Why?
|
| Carcinogens, Environmental | 1 | 2011 | 12 | 0.090 |
Why?
|
| Gastroscopy | 1 | 2011 | 98 | 0.090 |
Why?
|
| Dissection | 1 | 2011 | 55 | 0.090 |
Why?
|
| Water Supply | 1 | 2011 | 26 | 0.080 |
Why?
|
| Long-Term Care | 1 | 2011 | 69 | 0.080 |
Why?
|
| Acute-Phase Proteins | 1 | 2011 | 44 | 0.080 |
Why?
|
| Lipocalins | 1 | 2011 | 30 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8610 | 0.080 |
Why?
|
| Specimen Handling | 1 | 2011 | 146 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 409 | 0.080 |
Why?
|
| Pleural Cavity | 1 | 2010 | 6 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 3815 | 0.080 |
Why?
|
| Helicobacter pylori | 1 | 2019 | 1372 | 0.080 |
Why?
|
| Bone Density Conservation Agents | 2 | 2025 | 56 | 0.080 |
Why?
|
| Helicobacter Infections | 1 | 2019 | 1312 | 0.080 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2014 | 369 | 0.080 |
Why?
|
| Stroke | 1 | 2017 | 1059 | 0.070 |
Why?
|
| Safety | 1 | 2010 | 214 | 0.070 |
Why?
|
| Patient Care | 1 | 2010 | 98 | 0.070 |
Why?
|
| Risk Factors | 3 | 2020 | 11020 | 0.070 |
Why?
|
| Postmenopause | 2 | 2023 | 134 | 0.070 |
Why?
|
| Inflammation | 1 | 2016 | 1481 | 0.070 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2010 | 193 | 0.070 |
Why?
|
| Gastric Mucosa | 1 | 2011 | 491 | 0.070 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 463 | 0.070 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 91 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 2580 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 597 | 0.060 |
Why?
|
| Postoperative Care | 1 | 2009 | 293 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 2111 | 0.060 |
Why?
|
| Procollagen | 1 | 2025 | 14 | 0.060 |
Why?
|
| Osteoporotic Fractures | 1 | 2025 | 30 | 0.050 |
Why?
|
| Collagen Type I | 1 | 2025 | 110 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2025 | 197 | 0.050 |
Why?
|
| Hospitals, Veterans | 1 | 2026 | 335 | 0.050 |
Why?
|
| Radius | 1 | 2023 | 37 | 0.050 |
Why?
|
| Population Surveillance | 1 | 2026 | 394 | 0.050 |
Why?
|
| Phthalic Acids | 1 | 2023 | 11 | 0.050 |
Why?
|
| Absorptiometry, Photon | 1 | 2023 | 194 | 0.050 |
Why?
|
| Cadmium | 1 | 2023 | 33 | 0.050 |
Why?
|
| Benzoates | 1 | 2023 | 24 | 0.050 |
Why?
|
| Acrylamides | 1 | 2023 | 28 | 0.050 |
Why?
|
| Peptides | 1 | 2025 | 707 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2025 | 687 | 0.040 |
Why?
|
| Finland | 1 | 2020 | 46 | 0.040 |
Why?
|
| Public Health | 1 | 2022 | 269 | 0.040 |
Why?
|
| Geography | 1 | 2020 | 114 | 0.040 |
Why?
|
| European Union | 1 | 2020 | 13 | 0.040 |
Why?
|
| Food, Fortified | 1 | 2020 | 64 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 5184 | 0.040 |
Why?
|
| Drinking Water | 1 | 2020 | 15 | 0.040 |
Why?
|
| Secretory Pathway | 1 | 2019 | 10 | 0.040 |
Why?
|
| Water Purification | 1 | 2020 | 20 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2019 | 59 | 0.040 |
Why?
|
| PPAR alpha | 1 | 2019 | 54 | 0.040 |
Why?
|
| Postprandial Period | 1 | 2019 | 90 | 0.040 |
Why?
|
| STAT5 Transcription Factor | 1 | 2019 | 93 | 0.040 |
Why?
|
| Gluconeogenesis | 1 | 2019 | 93 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2020 | 760 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2020 | 298 | 0.030 |
Why?
|
| Fascia | 1 | 2018 | 16 | 0.030 |
Why?
|
| Ligands | 1 | 2019 | 478 | 0.030 |
Why?
|
| Fasting | 1 | 2019 | 303 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 723 | 0.030 |
Why?
|
| Global Health | 1 | 2022 | 623 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2019 | 347 | 0.030 |
Why?
|
| Triglycerides | 1 | 2019 | 602 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2019 | 398 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 1165 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2025 | 3690 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 613 | 0.030 |
Why?
|
| Calcium | 1 | 2020 | 1008 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 1362 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 2111 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 2078 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2900 | 0.020 |
Why?
|
| Algorithms | 1 | 2020 | 1674 | 0.020 |
Why?
|
| Gastroscopes | 1 | 2011 | 7 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1874 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3818 | 0.020 |
Why?
|
| Greece | 1 | 2011 | 12 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 2320 | 0.020 |
Why?
|
| Lipocalin-2 | 1 | 2011 | 29 | 0.020 |
Why?
|
| Sutures | 1 | 2011 | 63 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 4700 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 2014 | 534 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1589 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 3041 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4663 | 0.020 |
Why?
|
| Swine | 1 | 2011 | 1182 | 0.020 |
Why?
|
| Pregnancy | 1 | 2020 | 7476 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 4661 | 0.020 |
Why?
|
| Endovascular Procedures | 1 | 2014 | 795 | 0.010 |
Why?
|
| Animals | 2 | 2019 | 33743 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 5049 | 0.010 |
Why?
|